期刊文献+

PLGA材料仿生改性的最新进展 被引量:2

Latest advancement of poly lactic acid-glycolic acid (PLGA) materials bionic modification
下载PDF
导出
摘要 聚乳酸-乙交酯(PLGA)因具有优良的可降解性而在医用生物材料中得到了广泛应用,然而由于其表面缺乏细胞识别位点,以及存在亲水性和细胞亲和性不足等缺点,影响了细胞在其表面的粘附生长。为了得到生物功能和亲水性均较理想的聚乳酸类生物降解高分子,通过物理或者化学的方法在材料中引入胶原或多肽对其进行改性,赋予材料生物信号,以提高其生物功能,使其在组织工程支架的研究和临床应用更加广泛。该文主要对PLGA仿生改性的最新进展进行综述。 Poly(lactic co-glycolic acid) (PLGA) has the ability of degrdation which leads this kind of material applied widely to medical biomaterials. However, because the PLGA material lacks of surface cell discrimination points and has poor ability ofhydrophilia and cellular affinity, surface cell adherent growing is poor. Therefore modification is needed in order to obtain ideal materials with fine bio-function and good hydrophilia, wherein physical and chemical method are used by introducing collagen and polypeptide endowing PLGA with bio-signal to improve the bio-property. After this kind of modification, PLGA will be applied extensively in tissue engineering study and clinic in the future. The present review facused on latest advancement of bionic modificationg for PLGA.
出处 《粉末冶金材料科学与工程》 EI 2008年第6期323-329,共7页 Materials Science and Engineering of Powder Metallurgy
基金 国家自然科学基金资助项目(50174059)
关键词 聚丙交酯-乙交酯(PLGA) 降解聚合物 亲水性 仿生改性 (LLA-GA)PLGA biodegradable polymer hydrophilia bionic modification
  • 相关文献

参考文献28

  • 1[2]PARIENTE J L,BORDENOVE L,BAREILLE R,et al.The biocompatibility of catheters and stents used on urology[J].Progrés en urologie,1998,8(2):181-187.
  • 2[5]LU L C,PETER S J,LYMAN M D,et al.In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid)foams[J].Biomaterials,2001,22(8):865-872.
  • 3[9]GAO Q W,LAN P,SHAO H L,et al.Direct synthesis with meltpolycondensation and microstructure analysis of poly(L-lactic acid-co-glycolic acid)[J].Polymer Journal,2002,34(11):786-793.
  • 4[12]ATHANASSIO U G,DELIGIANNI D.Adhesion strength of individual human bone marrow cells to fibronectin.Integrinβ1-mediated adhesion[J].Journal of Materials Science:Materials in Medicine,2001,12(10/12):965-967.
  • 5[13]LEBARoNR G,ATHANASIOU K A.Extracellular matrix cell adhesion peptides:Functional applications in orthopedic materials[J].Tissue Engineering,2000,6(2):85-89.
  • 6[14]WILLIAMSON M R,BLACK R,KIELTY C.PCL-PU composite vascular scaffold production for vascular tissue engineering:Attachment,proliferation and bioactivity of human vascular endothelial cells[J].Biomaterials,2006,27(19):3608-3616.
  • 7[15]GU J W,YANG Y L,ZHU H S.Surface modification of silk fibroin film by plasma treatment and in vitro antithr ombogenicity study[J].Materials Science and Engineering C,2002,20(1/2):199-202.
  • 8[16]RYU G H,YANG W S,ROH H W,et al.Plasma surface modification of poly(D,L-lactic-co-glycolic -acid)(65/35)film for tissue engineering[J].Surface and Coatings Technology,2005,193(1/3):60-64.
  • 9[17]QUIRK R A,CHAN W C,DAVIESM C,et al.Poly(L-lysine)-GRGDS as a biomimetic surface modifier of poly(lactic acid)S[J].Biomatarials,2001,22(8):865-872.
  • 10[18]SHEN H,HU X X,YANG F,et al.Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide)[J].Biomateriais,2007,28(29):4219-4230.

二级参考文献12

  • 1Won C Y, Chu C C, Lee J D. Synthesis and characterization of biodegradable poly( L -aspartic acid- co -PEG)[J]. J Polym Sci, Polym Chem, 1998, 36: 2949-2959.
  • 2Won C Y, Chu C C, Lee J D. Novel biodegradable copolymers containing pendent amine functional groups based on aspartic acid and poly(ethylene glycol)[J]. Polymer, 1998, 39(25): 6677-6681.
  • 3Mozingo R, Adkins H, Carnahan J E. Palladium catalysts[J]. Organic Syntheses, 1946, 26: 77-82.
  • 4Caron A, Braud C, Bunel C, et al. Block structure of copolymers obtained by Pb/C-catalysed hydrogenolysis of benzyl protecting groups as shown by sequence-selective hydrolytic degradation in poly( β -malic acid) derivatives[J]. Polymer, 1990, 31: 1797-1802.
  • 5Yokoyama M, Inoue S, Kataoka K, et al. Molecular design for missile drug: Synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carriers[J]. Makromol Chem, 1989, 190: 2041-2054.120
  • 6Kimura Y, Shirotani K, Yamane H, et al. Copolymerization of 3(S)-[(benzyloxycarbonyl) methyl]- 1,4-dioxane-2,5-dione and L -lactide: a facial synthetic method for functionalized bioabsorbable polymer[J]. Polymer, 1993, 34(8): 1741-1748.
  • 7Feng Y, Klee D, Hcker H. Synthesis of poly[(lactic acid)- alt - co -p[(S)-aspartic acid)] from (3S, 6R, S)-3-[ (benzyloxycarbonyl) methyl]-6-methylmorpholine-2,5-dione[J]. Macromol Chem Phys, 2002, 203: 819-824.
  • 8Lu L C, Peter S J, Lyman M D, et al. In vitro and in vivo degradation of porous poly(dl-lactic- co -glycolic acid) foams[J]. Biomaterials, 2001, 22: 865-872.
  • 9Elisseeff J, Anseth K, Langer R, et al. Synthesis and characterization of photo-cross-linked polymers based on poly( L -lactic acid- co - L -aspartic acid)[J]. Macromolecules, 1997, 30: 2182-2184.
  • 10Cook A D, Hrkach J S, Langer R, et al. Characterization and development on RGD-peptide-modified poly(lactic acid- co -lysine) as an interactive resorbable biomaterials[J]. J Biomed Mater Res, 1997, 35: 513-525.

共引文献22

同被引文献30

  • 1何文 ,匡长春 ,张洪 ,陈健 .壳聚糖的分子参数对载药壳聚糖纳米粒体外性质的影响研究[J].中国药学杂志,2005,40(6):438-440. 被引量:17
  • 2王晶,周庆颂,袁悦,莫凤奎.生物降解聚合物PLGA-PEG-PLGA的合成及表征[J].沈阳药科大学学报,2005,22(5):348-351. 被引量:10
  • 3Gaumet M, Gumy R, Delie F. Interaction of biodegradable nanoparti- cles with intestinal ceils: the effect of surface hydrophilicity [ J ]. Int J Pharm,2010,390( 1 ) :45 - 52.
  • 4Femandes MM, Francesko A, Torrent-Burques J, et al. Sonoche- mically processed cationic nanocapsules: efficient antimicro- bials with film disturbing capacity[J]. Biomacromolecules, 2014, 15(4): 1365-1374.
  • 5Zhao J, Ohba S, Shinkai M, et al. Icariin induces osteogenic diff- erentiation in vitro in a BMP- and Runx2-dependent manner[J]. Biochem Biophys Res Commun, 2005, 369(2): 444-448.
  • 6Hsieh TP, Sheu SY, Sun JS, et al. lcariin isolated from epimedi- umpubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfal expression [J]. Phytomedicine, 2010, 17 (6): 414-423.
  • 7Liang W, Lin M, Li X, et al. Ieariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line[J]. Int J Mol Med, 2012, 30(4): 889-895.
  • 8Ronga M, Fagetti F, Canton G, et al. Clinical applications of gro- wth factors in bone injuries: experience with BMPs injury[J]. Inj- ured, 2013, 44(Suppl 1): S34-S39.
  • 9Diesner SC, Wang XY, Jensen-Jarolim E, et al. Use of lectin- functionalized particles for oral immunotherapy[J]. Ther Deliv, 2012, 3(2): 277-290.
  • 10Mahapatro A, Singh DK. Biodegradable nanoparticles are excel- lent vehicle for site directed in-vivo delivery of drugs and vacci- nes[J]. Journal of Nanobiotechnology, 2011, 9: 55-55.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部